CMS
  • Partnering
  • Contact
    • Contact Information
    • Join Us
  • CN
  • EN
  • AI Discovery
  • About Us
    • CMS Overview
    • Leadership
    • Milestones
    • Sustainability
  • Innovation
    • R&D Overview
    • Pipeline
  • Business
    • Business Overview
    • Cardio-cerebrovascular and Gastroenterology
    • Skin Health Business
    • Ophthalmology
    • Southeast Asia & the Middle East Business
  • News
    • Company News
    • Partner News
    • Video News
  • Investors
    • Stock Infomation
    • Financial Highlights
    • Information Disclosure
    • Corporate Governance
    • Investor Communication
  • Home
  • About Us
    • CMS Overview
    • Leadership
    • Milestones
    • Sustainability
  • Innovation
    • R&D Overview
    • Pipeline
  • Business
    • Business Overview
    • Cardio-cerebrovascular and Gastroenterology
    • Skin Health Business
    • Ophthalmology
    • Southeast Asia & the Middle East Business
  • News
    • Company News
    • Partner News
  • Investors
    • Investors
    • Stock Infomation
    • Financial Highlights
    • Information Disclosure
    • Corporate Governance
  • Partnering
  • Contact
    • Contact Information
    • Join Us
  • CN
  • EN
×
Ranked in the list of Forbes on “China’s Best Up-And-Coming Businesses” for two consecutive years
2022-07-08

Ranked in the list of Forbes on “China’s Best Up-And-Coming Businesses” for two consecutive years

Shenzhen Kangzhe was awarded the “Top 100 Enterprises in Shenzhen” and “Top 100 Corporate Taxpayers in Nanshan District”

Shenzhen Kangzhe was awarded the “Top 100 Enterprises in Shenzhen” and “Top 100 Corporate Taxpayers in Nanshan District”

Acquired 100% equity interest of Tianjin Precede Medical Trade Development Co., Ltd. (renamed as Tianjin Kangzhe Pharmaceutical Technology Development Co., Ltd. In October 2011)

Acquired 100% equity interest of Tianjin Precede Medical Trade Development Co., Ltd. (renamed as Tianjin Kangzhe Pharmaceutical Technology Development Co., Ltd. In October 2011)

  • About Us
    • CMS Overview
    • Leadership
    • Milestones
    • Sustainability
  • Innovation
    • R&D Overview
    • Pipeline
  • Business
    • Business Overview
    • Cardio-cerebrovascular and Gastroenterology
    • Skin Health Business
    • Ophthalmology
    • Southeast Asia & the Middle East Business
  • News
    • Company News
    • Partner News
    • Video News
  • Investors
    • Stock Infomation
    • Financial Highlights
    • Information Disclosure
    • Corporate Governance
    • Investor Communication
  • Privacy
  • Terms Of Use
All rights reserved by CMS Group 2001-2022 ERP of CMS Group
互联网药品信息服务备案凭证:(粤)-非经营性-粤网药信备字〔2026〕第00023号| 粤ICP备18157737号| 粤公网安备 44030502003605号